Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of rabies
3.2.1.2 Rising pet ownership globally
3.2.1.3 Favorable government regulations and policies
3.2.1.4 Increased awareness about rabies and its prevention
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of rabies vaccines
3.2.2.2 Lack of awareness
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Companion animals
5.2.1 Dogs
5.2.2 Cats
5.2.3 Other companion animals
5.3 Livestock animals
5.3.1 Cattle
5.3.2 Sheep & goats
5.3.3 Other livestock animals
5.4 Wildlife
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Pre exposure prophylaxis
6.3 Post exposure prophylaxis
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Injectable
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals & clinics
8.3 Animal shelters & rescue organizations
8.4 Research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Biogénesis Bago S.A.
10.2 Bioveta, a.s.
10.3 Boehringer Ingelheim International GmbH
10.4 Ceva Santé Animale S.A.
10.5 Dyntec
10.6 Elanco Animal Health Incorporated
10.7 Indian Immunologicals Limited
10.8 Merck & Co., Inc.
10.9 Vaxxinova International B.V.
10.10 Virbac S.A.
10.11 Zoetis Inc.
